FormerXBC Inc XEBEQ

RE:RE:RE:RE:RE:RE:RE:Inmatec

[SORNG1]

It is my understanding that US hospitals have very little on site generation of oxygen.  They are largely supplied by oxygen tanks from an outside provider.  Pre-COVID that has worked because total oxygen needs and costs have been relatively low and the inestment for onsite oxygen generation was not economoical.  COVID has changed that dramatically.  COVID patients primarily need high volume oxygen support, and without oxygen they die as shown in the present disaster in India.  Inmatec is having significant sales in India.  As oxygen costs using delivered oxygen tanks ramps up in large US hospitals, it will make more sense to develop on site oxygen generation rather than continue oxygen tank delivery from an outside provider.  Excess oxygen produced could be sold to smaller hospitals.  What Inmatec has done in the last 75 years is potentially peanuts compared to the huge need for oxygen related to COVID now and in the future.  Inmatec is in the perfect position to provide onsite oxygen generation to hospitals worldwide.  The combined sales forces of Inmatec, Xebec, and HyGEAR will greatly expand the name recognition for On Site Oxygen Production by Inmatec.  Past revenues over the last 75 years for Inmatec will bear very little resemblance to the future potential revenues from the future market for onsite oxygen generation at hospitals world wide.  Add the potential growth of Biostream for RNG production at any size organic waste site and HyGEAR for onsite production of Green Hydrogen usinf RNG and the future of Xebec Adsorption looks very promising.